BioCentury | Feb 3, 2017
Finance

Hustle and fund

...research fellow at the Whitehead Institute for Biomedical Research . Stuelpnagel was a VC at CW Group...
BioCentury | Jul 9, 2016
Financial News

Lux's Bock passes away

...co-founder and executive chairman of Nanosys Inc. (Palo Alto, Calif.), a managing general partner at CW Group...
BioCentury | Apr 4, 2007
Financial News

Surface Logix raises $20 million

...of a $52 million series D round led by Venrock Associates and Arch Venture Partners. CW Group...
BioCentury | Nov 11, 2005
Financial News

Nanosys raises $40 million

...Capital; Medtronic (MDT); Wasatch Advisors; Alexandria Real Estate Equities; Arch Venture Partners; CDIB BioScience Ventures; CW Group...
BioCentury | Oct 29, 2005
Financial News

Surface Logix raises $32 million

...round led by Venrock and Arch Venture. New investor Unilever Technology Ventures joined existing investors CW Group...
BioCentury | Apr 26, 2004
Finance

Ebb & Flow

...$38.9 million in cash. Principal stockholders include Arch Venture Partners (14.7% prior to the offering); CW Group...
BioCentury | Mar 15, 2004
Finance

'A' for effort

...Maxygen Spun out of Maxygen Amphora $25.0 9/27/01 Chemistry; genomics U.S. Arch Venture Partners; CalPERS; CW Group...
BioCentury | Dec 23, 2002
Finance

Ebb & Flow

...million in a series B round that included ARCH Venture Partners; MPM Capital; Venrock Associates; CW Group...
BioCentury | Dec 17, 2002
Financial News

Amphora raises $23 million

...million in a series B round led by ARCH Venture Partners; MPM Capital; Venrock Associates; CW Group...
BioCentury | May 6, 2002
Finance

Ebb & Flow

...its Pyridorin to treat diabetic kidney disease. Surface Logix's round included HBM BioVentures; CalPERS; Venrock; CW Group...
Items per page:
1 - 10 of 31
BioCentury | Feb 3, 2017
Finance

Hustle and fund

...research fellow at the Whitehead Institute for Biomedical Research . Stuelpnagel was a VC at CW Group...
BioCentury | Jul 9, 2016
Financial News

Lux's Bock passes away

...co-founder and executive chairman of Nanosys Inc. (Palo Alto, Calif.), a managing general partner at CW Group...
BioCentury | Apr 4, 2007
Financial News

Surface Logix raises $20 million

...of a $52 million series D round led by Venrock Associates and Arch Venture Partners. CW Group...
BioCentury | Nov 11, 2005
Financial News

Nanosys raises $40 million

...Capital; Medtronic (MDT); Wasatch Advisors; Alexandria Real Estate Equities; Arch Venture Partners; CDIB BioScience Ventures; CW Group...
BioCentury | Oct 29, 2005
Financial News

Surface Logix raises $32 million

...round led by Venrock and Arch Venture. New investor Unilever Technology Ventures joined existing investors CW Group...
BioCentury | Apr 26, 2004
Finance

Ebb & Flow

...$38.9 million in cash. Principal stockholders include Arch Venture Partners (14.7% prior to the offering); CW Group...
BioCentury | Mar 15, 2004
Finance

'A' for effort

...Maxygen Spun out of Maxygen Amphora $25.0 9/27/01 Chemistry; genomics U.S. Arch Venture Partners; CalPERS; CW Group...
BioCentury | Dec 23, 2002
Finance

Ebb & Flow

...million in a series B round that included ARCH Venture Partners; MPM Capital; Venrock Associates; CW Group...
BioCentury | Dec 17, 2002
Financial News

Amphora raises $23 million

...million in a series B round led by ARCH Venture Partners; MPM Capital; Venrock Associates; CW Group...
BioCentury | May 6, 2002
Finance

Ebb & Flow

...its Pyridorin to treat diabetic kidney disease. Surface Logix's round included HBM BioVentures; CalPERS; Venrock; CW Group...
Items per page:
1 - 10 of 31